Do you want to read an article? Please log in or register.
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD
Further Publications
RECOMMENDED
Related content
COPD
Pulmonary vascular structure and function are related to exercise capacity in health and COPD
Chest
Collins SÉ, Kirby M, Smith BM, Tan W, Bourbeau J, Thompson S, van Diepen S, Jensen D, Stanojevic S, Stickland MK, CanCOLD Collaborative Research Group and the Canadian Respiratory Research Network
doi: 10.1016/j.chest.2024.09.027
Further Publications
The one-minute sit-to-stand test: A practical tool for assessing functional exercise capacity in patients with COPD in routine clinical practice
Chron Respir Dis
Mellaerts P, Demeyer H, Blondeel A, Vanhoutte T, Breuls S, Wuyts M, Coosemans I, Claes L, Vandenbergh N, Beckers K, Bossche LV, Stylemans D, Janssens W, Everaerts S, Troosters T
doi: 10.1177/14799731241291530
RECOMMENDED
COPD
Influence of heart failure (HF) comorbidity in chronic obstructive pulmonary disease (COPD) and isolated forms of HF and COPD on cardiovascular function during hospitalization
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Schafauser NS, Sampaio LMM, Heubel AD, Kabbach EZ, Kawakami DMO, Leonardi NT, Castello-Simões V, Borghi-Silva A, Mendes RG
doi: 10.1016/j.rmed.2024.107731
COPD
Development and Validation of a Quantitative Score for the Criteria Clinical Control in Stable COPD Proposed in the Spanish COPD Guidelines (GesEPOC): Results of the EPOCONSUL Audit
J Clin Med
Calle Rubio M, Cataluña JJS, Miravitlles M, Navarrete BA, López-Campos JL, Ferrer MEF, Rodríguez Hermosa JL
doi: 10.3390/jcm14030707
RECOMMENDED
Pulmonary Fibrosis
Sweat chloride reflects CFTR function and correlates with clinical outcomes following CFTR modulator treatment
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Cyst Fibros
Zemanick ET, Ramsey B, Sands D, McKone EF, Fajac I, Taylor-Cousar JL, Mall MA, Konstan MW, Nair N, Zhu J, Arteaga-Solis E, Van Goor F, McGarry L, Prieto-Centurion V, Sosnay PR, Bozic C, Waltz D, Mayer-Hamblett N
doi: 10.1016/j.jcf.2024.12.006
COPD
Efficacy and safety of ensifentrine in treatment of COPD: a systematic review and meta-analysis of clinical trials
Ther Adv Respir Dis
Hammadeh BM, Younis OM, Alsufi MI, Idrees M, Hussein AM, Aldalati AY, Qtaishat FA, Qatawneh B, Bugazia A, Hamed RA
doi: 10.1177/17534666251347775
RECOMMENDED
COPD
Comparison of clinically meaningful improvements following center-based and home-based tele rehabilitation in people with COPD
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Chest
Cox DNS, McDonald DC, Burge DAT, Hill DCJ, Bondarenko MJ, Holland PAE
doi: 10.1016/j.chest.2024.11.001
COPD
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores
Respir Med
Vogelmeier CF, Rabe KF, Bhatt SP, Hanania NA, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Maloney J, Dakin P, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM
doi: 10.1016/j.rmed.2025.108015
RECOMMENDED
Further Publications
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized, Controlled Clinical Trial
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Am J Respir Crit Care Med
Xu AY, Velásquez GE, Zhang N, Chang VK, Phillips PP, Nahid P, Dorman SE, Kurbatova EV, Whitworth WC, Sizemore E, Bryant K, Carr W, Brown NE, Engle ML, Nhung NV, Nsubuga P, Diacon A, Dooley KE, Chaisson RE, Swindells S, Savic RM, Tuberculosis Trials Consortium (TBTC) Study 31/AIDS Clinical Trials Group (ACTG) A5349 study team
doi: 10.1164/rccm.202401-0165OC